Ciavor 5 5mg FC talet
PDF Leaflet Revision Date: 11 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of erectile dysfunction.
Dosage (summary)
2.5 to 5 mg once daily.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- CYP3A4 inhibitors
- Antihypertensive medications
- Organic nitrates
Contraindications
- Hypersensitivity to tadalafil
- Severe hepatic insufficiency
- Use with nitrates
Common side effects
- Headache
- Flushing
- Dyspepsia
- Back pain
Counselling Points
- Take at the same time daily
- Avoid use with nitrates
- Seek medical help for prolonged erections
Serious warnings
- Cardiac risk in patients with cardiovascular disease
- Risk of NAION
- Priapism
Important Disclaimer
The Ciavor 5 5mg FC talet professional information leaflet below is the property of Eli Lilly (SA) and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
